GU Ventures
Profile and portfolio
GU Ventures is the corporate venture arm of University of Gothenburg, an education company. It was founded in 1995 and is based in Gothenburg, Sweden. It invests from pre-seed to seed. Sectors it names: biotech and life sciences, medical devices, healthcare and digital health.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Pre-seed to Seed |
| Sectors | Biotech and life sciences, Medical devices, Healthcare and digital health |
| Geography | Europe |
| Offices | Gothenburg, Sweden |
Sources: S1 GU Ventures: mission (seed and early-stage investor in University of Gothenburg research); S2 GU Ventures: portfolio.
Where it invests and who leads it
Key facts
Portfolio
The firm's portfolio page lists 12 companies.S2
Every company on the GU Ventures list
12 companies, as listed on the firm's own website.S2 Read the firm's list.
- Alzinova
- Cellink
- Cereno Scientific
- Exocure
- Mimbly
- Navari Surgical
- Oncorena
- Pexa
- Serial X
- SimSen Diagnostics
- Surgical Science
- Videm
History
Official pages
Read the firm's own pages for current information.
Sources
- S1GU Ventures: mission (seed and early-stage investor in University of Gothenburg research)Firm
- S2GU Ventures: portfolioFirm
- S3GU Ventures: teamFirm
- S4GU Ventures: contact (Erik Dahlbergsgatan 11A, Goteborg)Firm
- S5GU Ventures: investment opportunities (funds and angel networks)Firm
- S6GU Ventures: aggregated results for 2024 (in Swedish)Firm
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by GU Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.